Outpatient use of antibiotics in uncomplicated diverticulitis decreases hospital admissions

IF 3.1 4区 医学 Q3 IMMUNOLOGY
Mark Ayoub, Carol Faris, Julton Tomanguillo Chumbe, Nadeem Anwar, Harleen Chela, Ebubekir Daglilar
{"title":"Outpatient use of antibiotics in uncomplicated diverticulitis decreases hospital admissions","authors":"Mark Ayoub,&nbsp;Carol Faris,&nbsp;Julton Tomanguillo Chumbe,&nbsp;Nadeem Anwar,&nbsp;Harleen Chela,&nbsp;Ebubekir Daglilar","doi":"10.1002/iid3.70031","DOIUrl":null,"url":null,"abstract":"<div>\n \n \n <section>\n \n <h3> Introduction</h3>\n \n <p>Recently, antibiotics use in uncomplicated acute diverticulitis (AD) has been controversial in Europe. The American Gastroenterological Association (AGA) in their 2015 guidelines recommend their selective use. Our study highlights their role in outpatient management.</p>\n </section>\n \n <section>\n \n <h3> Methods</h3>\n \n <p>We queried the Diamond Network through TriNetX-Research Network including 92 healthcare organizations. We included large intestine diverticulitis without perforation, abscess or bleeding. Exclusion criteria included any of sepsis criteria, CRP &gt; 15 mg/L, immunodeficiency or HIV, coronary artery disease, chronic kidney disease, history of Crohn's disease or ulcerative colitis, heart failure, hypertension, diabetes or any of the following in the 3 months before study date; clostridium difficile (C. diff) infection, diverticulitis or antibiotics. Patients with AD were divided into two cohorts; patients on antibiotics, and patients not on antibiotics. Cohorts were compared after propensity-score matching (PSM).</p>\n </section>\n \n <section>\n \n <h3> Results</h3>\n \n <p>214,277 patients met inclusion criteria. 58.9% received antibiotics, and 41% did not. After PSM, both cohorts had 84,320. Rate of hospital admission was lower in the antibiotic group (3.3% vs 4.2%, <i>p</i> &lt; .001). There was a statistical difference between ICU admission (0.1% vs 0.15%, <i>p</i> &lt; .01) and the rate of bowel perforation, peritonitis, abscess formation or bleeding (1.3% vs 1.4%, <i>p</i> = .044). There was no difference in mortality (0.1% vs 0.1%, <i>p</i> = .11), C. diff (0.1% vs 0.1%, <i>p</i> = .9), colectomies (0.2% vs 0.2%, <i>p</i> = .33), or Acute Kidney Injury (AKI) (0.1% vs 0.1%, <i>p</i> = .28).</p>\n </section>\n \n <section>\n \n <h3> Conclusion</h3>\n \n <p>Outpatient use of antibiotics in patients with uncomplicated AD is associated with lower rates of hospital admissions and complications without changing mortality rate or surgical intervention.</p>\n </section>\n </div>","PeriodicalId":13289,"journal":{"name":"Immunity, Inflammation and Disease","volume":"12 9","pages":""},"PeriodicalIF":3.1000,"publicationDate":"2024-09-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/iid3.70031","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Immunity, Inflammation and Disease","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/iid3.70031","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"IMMUNOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction

Recently, antibiotics use in uncomplicated acute diverticulitis (AD) has been controversial in Europe. The American Gastroenterological Association (AGA) in their 2015 guidelines recommend their selective use. Our study highlights their role in outpatient management.

Methods

We queried the Diamond Network through TriNetX-Research Network including 92 healthcare organizations. We included large intestine diverticulitis without perforation, abscess or bleeding. Exclusion criteria included any of sepsis criteria, CRP > 15 mg/L, immunodeficiency or HIV, coronary artery disease, chronic kidney disease, history of Crohn's disease or ulcerative colitis, heart failure, hypertension, diabetes or any of the following in the 3 months before study date; clostridium difficile (C. diff) infection, diverticulitis or antibiotics. Patients with AD were divided into two cohorts; patients on antibiotics, and patients not on antibiotics. Cohorts were compared after propensity-score matching (PSM).

Results

214,277 patients met inclusion criteria. 58.9% received antibiotics, and 41% did not. After PSM, both cohorts had 84,320. Rate of hospital admission was lower in the antibiotic group (3.3% vs 4.2%, p < .001). There was a statistical difference between ICU admission (0.1% vs 0.15%, p < .01) and the rate of bowel perforation, peritonitis, abscess formation or bleeding (1.3% vs 1.4%, p = .044). There was no difference in mortality (0.1% vs 0.1%, p = .11), C. diff (0.1% vs 0.1%, p = .9), colectomies (0.2% vs 0.2%, p = .33), or Acute Kidney Injury (AKI) (0.1% vs 0.1%, p = .28).

Conclusion

Outpatient use of antibiotics in patients with uncomplicated AD is associated with lower rates of hospital admissions and complications without changing mortality rate or surgical intervention.

Abstract Image

无并发症憩室炎患者在门诊使用抗生素可降低住院率
导言:最近,抗生素在无并发症急性憩室炎(AD)中的应用在欧洲引起了争议。美国胃肠病学会(AGA)在其 2015 年指南中建议有选择地使用抗生素。我们的研究强调了药物在门诊治疗中的作用。 方法 我们通过 TriNetX-Research 网络查询了钻石网络,其中包括 92 家医疗机构。我们纳入了无穿孔、脓肿或出血的大肠憩室炎。排除标准包括任何败血症标准、CRP > 15 mg/L、免疫缺陷或 HIV、冠状动脉疾病、慢性肾脏疾病、克罗恩病或溃疡性结肠炎病史、心力衰竭、高血压、糖尿病或在研究日期前 3 个月内出现过以下情况:艰难梭菌(C. diff)感染、憩室炎或抗生素。AD 患者被分为两组:使用抗生素的患者和未使用抗生素的患者。经过倾向分数匹配(PSM)后,对两组患者进行了比较。 结果 214 277 名患者符合纳入标准。58.9%的患者使用了抗生素,41%的患者没有使用。经过倾向分数匹配后,两组共有 84,320 名患者。抗生素组的入院率较低(3.3% vs 4.2%,p <.001)。入住重症监护室(0.1% vs 0.15%,p <.01)与肠穿孔、腹膜炎、脓肿形成或出血率(1.3% vs 1.4%,p = .044)之间存在统计学差异。在死亡率(0.1% vs 0.1%,p = .11)、C. diff(0.1% vs 0.1%,p = .9)、结肠切除术(0.2% vs 0.2%,p = .33)或急性肾损伤(AKI)(0.1% vs 0.1%,p = .28)方面没有差异。 结论 无并发症的 AD 患者在门诊使用抗生素可降低入院率和并发症发生率,但不会改变死亡率或手术干预。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Immunity, Inflammation and Disease
Immunity, Inflammation and Disease Medicine-Immunology and Allergy
CiteScore
3.60
自引率
0.00%
发文量
146
审稿时长
8 weeks
期刊介绍: Immunity, Inflammation and Disease is a peer-reviewed, open access, interdisciplinary journal providing rapid publication of research across the broad field of immunology. Immunity, Inflammation and Disease gives rapid consideration to papers in all areas of clinical and basic research. The journal is indexed in Medline and the Science Citation Index Expanded (part of Web of Science), among others. It welcomes original work that enhances the understanding of immunology in areas including: • cellular and molecular immunology • clinical immunology • allergy • immunochemistry • immunogenetics • immune signalling • immune development • imaging • mathematical modelling • autoimmunity • transplantation immunology • cancer immunology
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信